ABSTRACT The CRISPR/Cas9 discovery has emerged as a powerful technology tool to edit genomes, which allows researchers, innovators and life science entrepreneurs to alter DNA […] Read More
Category: Article
Has Lord Neuberger in Actavis introduced “an amorphous general inventive idea” test to determine UK patent infringement by equivalents? Are “inessential integers”, once found extremely […] Read More
ABSTRACT Second medical use patents and their claims do not only represent highly valuable inventions for both originator and generic pharmaceutical companies, but have also […] Read More
ABSTRACT In order to stimulate product development and innovation in the pharmaceutical industry, the United States Congress in 1984 enacted Title II of the Drug […] Read More
ABSTRACT Despite the therapeutical benefits of dosage regimes, being granted and securing patent protection for these types of inventions has always been difficult. Historically dosage […] Read More
INTRODUCTION In a world with an estimated population of 7.6 billion, 2 billion people lack access to medicines that are imperative to their health and […] Read More
Naming pharmaceuticals is a topic that has been thoroughly investigated and buzzed around, and where the world’s expertise agrees on at least one thing. With […] Read More